Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Immunovant Dives On Its C-Suite Sweep, Narrowed Plans For Leading Drug

Roivant Sciences is making serious changes to subsidiary Immunovant, announcing Monday a series of C-suite changes and new disease targets.

Investors Business Daily

More pharmacies offer to speed prescription deliveries to customers

America’s two largest retailers want to deliver prescriptions to your doorstep, sometimes in a matter of hours

The Independent UK

Ministers in ‘active conversation’ with UK drug firms over potential tariffs

Government seeks ways to shield industry from possible US levies amid concern over effect on medicine supply

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Leadership Through Kelli Rodriguez's Lens: Diversity, Communication, & Women's Empowerment

For more than 20 years, Rodriguez has played an instrumental role in launching, restructuring, and scaling global and domestic brands, cementing her reputation as an industry leader.

International Business Times

Trump Tariffs Unnerve Locals In Irish 'Pharma' Hub

Vast pharmaceutical factories pepper the green landscape in southern Ireland, but the wind turbines next to the plants outside Cork are in the eye of Donald Trump's global trade storm.

International Business Times

Argenx Bounds Off 200-Day Line On 'Best-Case Scenario' For Blockbuster Drug

Argenx stock jumped Friday after the FDA cleared its autoimmune disease drug, Vyvgart Hytrulo, for at-home treatment.

Investors Business Daily

Novartis Plans $23 Billion US Buildout as Pharma Faces Pressure From Trump

Novartis plans a $23 billion U.S. expansion to boost drug production and counter potential import tariffs.

Latin Times

Read news from The Economist, FT, and more,
with one subscription

IBD 50 Stock Flashes 'Golden Cross' But Massive Risk Looms

Ani Pharmaceuticals stock is near a buy point in a cup-with-handle base after flashing a "golden cross" signal.

Investors Business Daily

S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash

Pharma stocks tumbled Thursday after the Trump administration said the delay for reciprocal tariffs doesn't apply to sector-specific tariffs.

Investors Business Daily

This Medical Supplies Distributor Dodges A Tariff Bullet

This medical supplies distributor stock is off a recent high and back in a buy zone.

Investors Business Daily

Hedge Fund Managers Are Aggressively Buying Biotech Stocks Despite Trump Hinting at Pharma Tariffs

While Donald Trump spared pharma companies from his tariff announcement last week, he revealed yesterday plans to announce tariffs on the industry soon.

International Business Times

EU drug companies warn of exodus to US as Trump threatens import tariffs

Von der Leyen urged to take ‘rapid and radical action’ as president says tariffs on pharmaceuticals coming ‘shortly’

The Guardian - UK

China, America and pay inject drama into AstraZeneca’s AGM

The boss’s bonus is an annual debating point at Britain’s biggest company. But that’s not the only issue this year

The Guardian - UK

Painkillers without the addiction? The new wave of non-opioid pain relief

Pharma firms are developing drugs that avoid the brain’s opioid receptors to minimise the risks of dependence and overdoses, but not all experts are convinced

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Why IBD Stock Of The Day Quest Diagnostics Sidestepped The Sell-Off

Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling.

Investors Business Daily

Biotech Stocks Take A Tariffs Hit. Pharmaceuticals Are Exempt — For Now.

Biotech stocks toppled early Thursday after Trump announced broad global tariffs, including a 20% tariff on goods from Europe.

Investors Business Daily

IBD 50 Stock TG Therapeutics Rallies On A Setback For Chief Rival Roche

TG Therapeutics rallied Wednesday after Roche's rival multiple sclerosis treatment, Ocrevus, missed its mark in a study.

Investors Business Daily

Biotech Stocks Take Another Beating As 'Chaos' Reigns At FDA With Reports Of Mass Firings

Biotech stocks skidded again Tuesday as "chaos" reigned at the FDA with reports of mass firings, including the departure of a key official.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - US

Biotech group warns exit of top FDA vaccine official will ‘erode scientific standards’

Rare admonition from a sector that has largely been silent in the face of the second Trump administration

Evening Standard

Potential threat of US tariffs ‘not as stark’ as 2008 crash – Irish minister

Enterprise Minister Peter Burke said pharma tariffs could be ‘a double-edged sword’ for the US administration.

Investors Business Daily

Novo Nordisk Inks Its Second Big Obesity Deal In A Week — And It's Not For A GLP-1

Novo Nordisk will pay Lexicon Pharmaceuticals up to $1 billion to license its experimental obesity treatment.

Investors Business Daily

How IBD Stock Of The Day ADMA Biologics Shrugged Off Accounting Debacle For A Bullish Comeback

ADMA Biologics is Thursday's IBD Stock Of The Day. After an accounting debacle hammered shares in 2024, ADMA stock is making a comeback.

Investors Business Daily

Catalyst Pharma Battles To All-Time High After Huge Patent Lawsuit Win

This IBD 50 holding holds top notch ratings amid a market downturn.

Investors Business Daily

Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study

Viking Therapeutics stock skidded Wednesday despite the "encouraging" speed with which the company enrolled patients in an obesity study.

Al Jazeera

Why are users of 23andMe being urged to delete their data?

Genetic testing company’s bankruptcy proceedings could result in auction of the genetic data of 15 million users.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

Investor Business Daily

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.